http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102603621-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1cc134e139490e374ccf80c05d94857 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-68 |
filingDate | 2012-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8b4e57373bfe45f568c3bb5f00f94ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24ee37fa5b755ef36d543a418ea856ff |
publicationDate | 2012-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102603621-A |
titleOfInvention | A kind of novel chiral sulfoxide compound and the method for preparing esomeprazole sodium with this compound |
abstract | The invention discloses a (S)-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl) ethyl thioformate compound and its preparation method and The technology of preparing esomeprazole sodium with this compound, the remarkable advantage of the present invention is, synthetic raw material is cheap and easy to get, and reaction condition is gentle, the yield of preparation esomeprazole sodium salt is high, optical purity is high, safe to operate, to The environmental pollution is small, and it is more suitable for industrialized large-scale production. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104098516-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104098515-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104098515-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104557867-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104098516-A |
priorityDate | 2012-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.